Centanafadine Shows Promise in Phase 3 Trials for Adolescent ADHD
Other Articles in this Edition
William Pelham Jr., a groundbreaking researcher in children’s ADHD, dies at 75 in Miami
New genes linked to ADHD identified, potentially paving the way for new treatments
Motor, Behavioral, and Emotional ADHD Symptoms: Methylphenidate or Atomoxetine?
Viloxazine ER Maintains Safety, Efficacy for Long-Term Pediatric ADHD Treatment
Children with ADHD frequently use health care service before diagnosis, study finds
Prenatal complications and familial factors linked to ADHD symptoms in children
Centanafadine Shows Promise in Phase 3 Trials for Adolescent ADHD
New research looks at life satisfaction in pandemic-era teens with mental health histories
Unlicensed Stimulant Doses in Adult ADHD Barely Reduce Symptoms Compared to Licensed Doses
Individuals with ADHD who are evening types are more likely to have depressive symptoms
Surfing the web too much? Study links problematic internet use to heightened ADHD symptoms
Weighted blankets improve sleep in children with ADHD, study shows
How the prolonged ADHD medication shortage is straining patients and their families